Natural products targeting ferroptosis pathways in cancer therapy (Review)

Xin Na1, Lin Li2, Dongmei Liu1

  • 1School of Pharmaceutical Sciences & Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, P.R. China.

Oncology Reports
|July 26, 2024
PubMed

Insights

Natural products that induce ferroptosis (FIN) offer novel cancer treatment strategies. This review details FIN from natural sources, their mechanisms, and potential for drug development and combination therapies.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Ferroptosis inducers (FIN) are crucial for innovative cancer therapies.
  • Research on natural product-derived FIN is limited, especially for drug development and combination therapy.

Purpose of the Study:

  • To comprehensively review recent studies on ferroptosis.
  • To identify and elaborate on natural products with FIN functions.
  • To provide insights into clinical drug development, combination therapies, and resistance reversal.

Main Methods:

  • Categorization of ferroptosis causes into driving and defensive factors.
  • Elucidation of key ferroptosis pathways and targets.
  • Summarization and analysis of research on natural products inducing ferroptosis.

Main Results:

  • Key pathways and targets of ferroptosis were identified.
  • Natural products with ferroptosis-inducing functions were detailed.
  • Mechanisms of action, combination therapies, and resistance reversal strategies were analyzed.

Conclusions:

  • Natural products hold significant potential for cancer treatment via ferroptosis induction.
  • This review serves as a reference for utilizing natural compounds against cancer.
  • Further investigation into the therapeutic effects of natural FIN is encouraged.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K